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Abstract A parallel-group-design, randomized, unicentre
and blinded controlled study was undertaken to assess the
efficacy of a new fipronil-based spot-on formulation
applied once to dogs against experimental Ixodes ricinus
infestations. Six dogs served as negative controls (group 1),
six dogs served as positive controls (group 2) receiving the
original fipronil spot-on (Frontline® spot-on Dog, Merial)
at a dosage of 0.67 mL for a dog weighing from 2 to 10 kg
and 1.34 mL for a dog weighing from 10.1 to 20 kg and six
dogs were treated with a 10% w/v fipronil-based spot-on
solution (Effipro® Spot-on, Virbac SA) at an identical
dosage (group 3, 0.67 mL for a dog weighing from 2 to 10
kg and 1.34 mL for a dog weighing from 10.1 to 20 kg).
Each dog was sedated and subsequently infested with 50
unfed adult I. ricinus on days−7, −2, 7, 14, 21, 28 and 35.
Forty-eight hours after the treatment and 48 h after each
challenge (days −5, 2, 9, 16, 23, 30 and 37), the population
of the remaining ticks was assessed for each animal.
Geometric mean tick counts obtained were reduced by
99% and 94% on day2 in groups 2 and 3, respectively,
compared to the negative control group. Dogs were
protected from re-infestations with an efficacy of >90%
for 3 weeks in group 2 and for 5 weeks in group 3. Both
10% w/v fipronil-based spot-on solutions, despite different
vehicles, were equally able to eradicate tick infestation, to
prevent new infestations and were equally well tolerated.
Introduction
Hard-bodied ticks (family Ixodidae) are temporary parasites
that can transmit major systemic diseases as well as being a
local cause of inflammation and necrosis (Baxter et al.
2009). The frequency of vector-borne diseases in pets
(canine babesiosis, granulocytic anaplasmosis, canine
monocytic ehrlichiosis, thrombocytic anaplasmosis) is
increasing worldwide (Beugnet and Marie 2009; Fritz
2009). Ixodes ricinus, known as the sheep tick or castor
bean tick, is common in Europe (Lindgren et al. 2000; Gray
et al. 2009). In dogs, I. ricinus can be a vector of Borrelia
burgdorferi (Lyme disease) and Anaplasma phagocytophi-
lum (canine granulocytic anaplasmosis) (Greene 2006). All
stages of I. ricinus feed on humans, being able to transmit
several diseases to people, including Crimean–Congo
hemorrhagic fever and Lyme disease. Therefore, effective
tick control in dogs will help preventing canine diseases
and may indirectly contribute to prevent human diseases.
First available as a 0.25% spray, fipronil was then
marketed as a spot-on formulation (Postal et al. 1997;
Cruthers et al. 2001) and eventually it was combined with
S-methoprene (Young et al. 2003), also in a spot-on. More
recently, pyriprole from the same chemical group had been
launched and is available as a spot-on (Schuele et al.
2008). Finally, as fipronil’s patent has recently expired,
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new fipronil-based products are now present on the
market.
The present study was conducted to evaluate the
immediate and sustained efficacy and the tolerance of a
new spot-on formulation (Effipro® Spot-on, Virbac S.A.)
with the same qualitative and quantitative composition in
terms of active ingredient (fipronil) as the original product
(Frontline® Top spot, Merial) but with different vehicles.
The efficacy was evaluated against experimental infesta-
tions of I. ricinus in dogs. A positive reference control
group included dogs treated with the original product.
Materials and methods
Animals
Eighteen (nine female and nine male) Beagle dogs between 11
and 24 months old and weighing from 8.6 to 15.2 kg were
included in the study. Dogs were allocated randomly into three
groups of six and each dog was singly housed in a 3×1.4-m
pen. Saw dust was used as bedding in each pen. Petroleum
jelly barriers were placed around the pen perimeter to prevent
ticks from escaping from the pens. Dogs were fed a standard
dry commercial dog diet and water was available ad libitum.
They were acclimatized for 7 days prior to treatment.
Ticks and experimental infestations
Laboratory-reared adult I. ricinus with a male–female ratio
of 40:60 were obtained from Prof. Matuschka, Medizini-
sche Falkultät der Humboldt Universität zu Berlin Abt.
Parasitologie, Berlin, Germany. For each experimental
infestation, approximately 50 viable unfed ticks (30±2
females and 20±2 males) were applied to the dog. For the
infestations, dogs were sedated with ketamine (10 mg/kg)
combined with xylazine (2 mg/kg), both given intramuscu-
larly. Once sufficiently sedated, each dog was infested in its
pen; ticks were applied gently to the dorsal or lateral rump
area and allowed to crawl into the hair coat. Dogs were
infested 7 and 2 days prior to the treatments and 7, 14, 21,
28 and 35 days after the treatments.
Treatments
The study was of a parallel-arm, randomized block design,
single site and blinded controlled. The animals were not
treated by an individual involved in the post-treatment
assessments and observations. Study groups were coded by
colour to blind the staff performing post-treatment assess-
ments and observations. All animals were listed according to
their sex and within sex; animals were ranked from the lowest
to the highest study day −7 body weight. Where animals with
equal study day −7 body weight occurred, they were ranked in
order of decreasing animal number. Within each sex, the
animals were divided into blocks of three, with one dog in
each block assigned to each group using random order
numbers derived from Fisher and Yates tables.
The dogs in group 1 were not treated. The dogs in group
2 were treated with a 10% w/v fipronil-based spot-on
solution (Frontline® Spot-on Dog, Merial) at a dosage of
0.67 mL for a dog weighing from 2 to 10 kg and 1.34 mL
for a dog weighing from 10.1 to 20 kg. The dogs in group 3
were treated with the new fipronil spot-on (Effipro® Spot-
on, Virbac SA) at an identical dosage (0.67 mL for a dog
weighing from 2 to 10 kg and 1.34 mL for a dog weighing
from 10.1 to 20 kg). The solution used in group 3 had the
same qualitative and quantitative composition in terms of
active ingredient (fipronil) as Frontline® Spot-on Dog but
some vehicles were different. The treatment took place in
the pens in which the dogs were housed. The coat was
parted between the shoulder blades until the skin was
visible. The tip of the pipette was placed on the skin and
gently squeezed at one or two spots to empty its content on
the skin. Care was taken when applying the products to
reduce the chance of run-off. There was no run-off. Gloves
and protective clothing were changed between groups
during the study procedures to avoid cross-contamination.
The pipette application design (commercially used pipette
volume per body weight range and pipette application) was
preferred to come closer to the field situation. Application
was performed by a well-trained person, ensuring that the
pipette was completely emptied.
Concurrent treatments that may have had an antiparasitic
activity (e.g. any endo- or ecto-parasiticide) were not
allowed.
Clinical examinations and tick counting
General health observations were carried out on all dogs once
daily by a trained technician from day−7 to 37; when, in the
technician’s opinion, the health of a dog was abnormal, a
veterinary surgeonwas contacted. Dogs were weighed prior to
feeding on days−7, 3, 11, 25 and 37. Additionally, each
animal was submitted to a full clinical examination and skin
examination of the administration site prior to the administra-
tion of the products and 1, 3, 6, 24 and 48 h after dosing.
Behaviour, salivation, pupil constriction and the presence of
nervous signs were assessed and scored from 0 to 3:
1. Behaviour—0: normal behaviour, 1: dull, 2: head down
and not alert, 3: lethargic/moribund
2. Salivation—0: normal salivation, 1: slightly excessive
salivation, 2: excessive salivation, 3: profuse salivation
3. Pupil constriction—0: normal, 1: slightly constricted
pupil, 2: constricted pupil
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4. Nervous signs—0: normal behaviour, 1: slight excit-
ability and uncoordinated, 2: very excitable and
uncoordinated, 3: lateral recumbency and convulsions.
The skin at the administration site was assessed for
cosmetic changes, alopecia, erythema and edema. Any
cosmetic changes (e.g. clumping, matting, discoloration)
were recorded.
Forty-eight hours after the treatment and 48 hours
after each challenge (days−5, 2, 9, 16, 23, 30 and 37),
the population of remaining ticks was assessed for each
animal. To facilitate counting, the dogs were sedated
with the same aforementioned protocol. The dog was
then removed from its pen and placed on a table for the
evaluation procedure. The hair was pushed manually,
using the thumb, fingers or forceps, against its natural
lap such that the skin and ticks were exposed. The
examiner(s) systematically examined the head, all dorsal
and ventral areas and the legs of the dog. On day−5, the
number of live attached ticks were counted and recorded
and all ticks were removed. On all other tick counts, the
number of live attached and free (on dogs) ticks were
quantified and all ticks were removed from the dog.
Statistical analysis
Original data were entered in an Excel 2000 (Microsoft®
Office, Microsoft® Corporation) file and 100% verifica-
tion to the original data was performed. The Excel files
were imported into Minitab version 14 (Minitab SARL,
France), which was the software used for the statistical
analysis. For all analyses, the significance threshold was
α=0.05. The three groups were described and compared
before treatment (baseline) on the following criteria:
weight, age, pre-study day-5 tick attachment rates and
product application rate (mg fipronil/kg body weight).
Parameters were analysed using a Kruskal–Wallis test or
one-way ANOVA (body weight). Arithmetic and geomet-
ric means were calculated for each of the three groups at
each time point. For groups 2 and 3, efficacy was
calculated at each time point using the mean according
to the following formula:
Efficacy %ð Þ ¼ 100 meancontrol meantreatedð Þ=meancontrol
An effective dose was expected to provide >90%
reduction in tick counts compared to control. In addition,
tick counts were compared for all groups using Kruskal–
Wallis test. When there was a significant difference, the
individual groups were compared using Mann–Whitney or
Kruskal–Wallis test. If one group contained all zero counts,
Kruskal–Wallis test was used instead. In cases where data
sets contained a zero, geometric means were calculated by
adding 1 to all of the numbers. After the mean was
calculated, 1 was subtracted.
Results
Blinding of the study was not broken. The three groups
were homogenous at baseline on the following criteria: age,
weight, sex, pre-treatment tick attachment rate and product
application rate (mg fipronil/kg body weight) (Table 1). No
adverse events were recorded in any of the treatment groups
that could be related to the administration of either product.
All animals of group 2 (Frontline®) and group 3
(Effipro®) had clumping of the hairs at the application site
at 1, 3 and 6 h post-application. Greasiness of the hair was
observed at the application site in all animals of groups 2
and 3, 1 and 3 h after the treatment. Three dogs treated with
Frontline® had greasiness of the hair 6 hours post-dosing.
Two dogs which had received Effipro® showed hair
discoloration and white deposit on the application site 6 h
after application. One dog assigned to the Effipro® group
had white deposit on the hair on the application site 24 h
after the application.
The arithmetic mean numbers of ticks that were
present in the hair coat of the untreated control dogs
and on treated animals 48 h after each infestation are
graphically illustrated in Fig. 1. The efficacy, based on
geometric means, of both formulations of fipronil is
summarized in Table 2.
The results (Fig. 1; Table 2) show that the experimental
infestations with I. ricinus were successful, with a mean
percentage recovery of I. ricinus on the control dogs 48 h
after each infestation ranging between 37% (day 23) and
50.7% (day 9). Efficacy, based on tick reduction, was >90%
in dogs treated with Frontline® on days2, 9, 16 and 23 and
was >90% in dogs treated with Effipro® on all study days,
i.e. 2, 9, 16, 23, 30 and 37.
The differences in tick counts between the two groups
treated with a fipronil solution (groups 2 and 3) and the
control group (group 1) were significant on all study days
(p<0.01). On all study days, tick counts in group 2
(Frontline®) and group 3 (Effipro®) were not significantly
different.
Discussion
The recovery rates of at least 37% at all time points indicate
that the strain was sufficiently vigorous and that the dogs
used for the trial were adequately susceptible to Ixodes
infestation.
Both Effipro® and Frontline® formulations evaluated
in this study were effective in treating I. ricinus
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infestations with an efficacy of 94% and 99%, respective-
ly. The two formulations of fipronil prevented new
infestations for 5 weeks (Effipro®) and 3 weeks (Front-
line®), with an efficacy of >90% calculated at 48 h post-
challenge. The results obtained with the Frontline®
formulation were comparable with those obtained in
previous studies, where efficacy assessed at 48 h after a
tick challenge was >90% for 4 weeks against I. ricinus
(Pollmeier et al. 2001) and against I. scapularis (Dryden et
al. 2006).
The primary concern about tick is their ability to serve as
vectors of diseases. B. burgdorferi, the causal agent of
Lyme disease, is predominantly transmitted by Ixodes ticks.
The maximum transmission of the spirochete occurs
between 48 and 72 h after the nymph attachment (des
Vignes et al. 2001; Piesman and Dolan 2002; Greene
2006). Similarly, transmission of the human granulocytic
ehrlichiosis agent, A. phagocytophilum (formerly Ehrlichia
phagocytophyla), was estimated to require at least 30 h in
an experimental mice model infested with Ixodes nymphs.
Transmission by adults may occur later based on the fact
that adult Ixodes complete their blood meal in 7–9 days
compared with 3-4 days for nymphs (Katavolos et al.
1998).
Therefore, a killing effect obtained 48 h after the
infestation, such as in the present study, ensures an
adequate protection against Lyme disease agents and likely
protects against A. phagocytophilum.
Both products were well tolerated by all the animals
who received the treatments. Only cosmetic changes
(greasiness, clumping of the hair coat, white deposit)
were seen at the application site of both formulations;
they resolved by 24–48 h.
Both Effipro® Spot-on and Frontline® Top spot are
10% w/v fipronil-based spot-on solutions, but some of
their vehicles are different. The present study shows that,
despite different vehicles, the two formulations provided a
similar protection against I. ricinus infestation and that
they were equally well tolerated. These results are in
agreement with those previously obtained in a study
conducted in a similar manner on dogs experimentally
infested with fleas. Both 10% w/v fipronil-based spot-ons
were equally able to eradicate flea infestation, to prevent
new infestations and were equally well tolerated. Geo-
Fig. 1 Arithmetic mean (SD) of I. ricinus counts 48 h after treatment
with two 10% w/v fipronil-based spot-on solutions on day0 and 48 h
after each re-infestation with 50 young adult ticks
Table 1 Means (standard deviation; n=6), median, minimal and maximal values of age, weight, pre-treatment tick attachment rate and
application rate from dogs treated with one of the two 10% w/v fipronil-based spot-on solutions or left untreated
Variable Treatment group Mean (standard deviation) Median Min–max
Age (months) Negative control 13.8 (2.40) 13.0 12.0–18.0
Frontline® 15.5 (1.76) 15.0 14.0–18.0
Effipro® 13.7 (5.47) 12.5 8.0–24.0
Weight (kg) Negative control 11.8 (2.13) 11.2 9.5–15.2
Frontline® 11.5 (2.07) 10.6 9.6–15.0
Effipro® 11.7 (2.35) 11.3 8.6–15.0
Pre-treatment tick attachment rate (%) Negative control 62.2 (11.5) 60.0 50.0–76.7
Frontline® 63.3 (14.0) 63.3 46.7–83.3
Effipro® 65.0 (16.4) 65.0 43.3–90.0
Application rate (fipronil, mg/kg BW) Frontline® 10.6 (2.52) 11.1 6.7–13.1
Effipro® 10.4 (1.97) 10.4 7.8–12.9
Table 2 Mean geometric efficacy (%) of two 10% w/v fipronil-based
spot-on solutions applied to dogs experimentally infested with I. ricinus,
calculated 48 h after the treatment and 48 h after each re-infestation
Days after treatment
2 9 16 23 30 37
Frontline® 98.8 100.0 100.0 100.0 86.3 77.2
Effipro® 93.8 100.0 100.0 98.9 97.9 94.1
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metric mean flea counts obtained were reduced by 99.7%
and 100% in the groups treated with Effipro® Spot-on and
Frontline® Top spot, respectively, on day2, compared to
the negative control group. Dogs were protected from re-
infestations with an efficacy of >95% for 93 days in the
group treated with Effipro® Spot-on and for 79 days in the
group treated with Frontline® Top spot (Bonneau et al.
2010).
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